DK2119700T3 - Benzylaminderivat eller farmaceutisk acceptabelt syreadditionssalt heraf og anvendelse heraf til medicinske formål - Google Patents

Benzylaminderivat eller farmaceutisk acceptabelt syreadditionssalt heraf og anvendelse heraf til medicinske formål

Info

Publication number
DK2119700T3
DK2119700T3 DK08704230.5T DK08704230T DK2119700T3 DK 2119700 T3 DK2119700 T3 DK 2119700T3 DK 08704230 T DK08704230 T DK 08704230T DK 2119700 T3 DK2119700 T3 DK 2119700T3
Authority
DK
Denmark
Prior art keywords
pharmaceutically acceptable
acid addition
addition salt
acceptable acid
medical purposes
Prior art date
Application number
DK08704230.5T
Other languages
English (en)
Inventor
Ryoji Hayashi
Tsukasa Kikuchi
Masaki Arai
Satoshi Kurosawa
Ko Hasebe
Sayoko Kanie
Seiichiro Ozono
Atsushi Otsuka
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of DK2119700T3 publication Critical patent/DK2119700T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
DK08704230.5T 2007-01-31 2008-01-31 Benzylaminderivat eller farmaceutisk acceptabelt syreadditionssalt heraf og anvendelse heraf til medicinske formål DK2119700T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007020582 2007-01-31
PCT/JP2008/051479 WO2008093767A1 (ja) 2007-01-31 2008-01-31 ベンジルアミン誘導体またはその薬学的に許容される酸付加塩、およびその医薬用途

Publications (1)

Publication Number Publication Date
DK2119700T3 true DK2119700T3 (da) 2012-10-22

Family

ID=39674074

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08704230.5T DK2119700T3 (da) 2007-01-31 2008-01-31 Benzylaminderivat eller farmaceutisk acceptabelt syreadditionssalt heraf og anvendelse heraf til medicinske formål

Country Status (12)

Country Link
US (1) US8148427B2 (da)
EP (1) EP2119700B1 (da)
JP (1) JP4720909B2 (da)
KR (1) KR101479048B1 (da)
CN (1) CN101595088B (da)
AU (1) AU2008210637B2 (da)
CA (1) CA2677061C (da)
DK (1) DK2119700T3 (da)
ES (1) ES2387586T3 (da)
PL (1) PL2119700T3 (da)
PT (1) PT2119700E (da)
WO (1) WO2008093767A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198330B2 (en) 2008-07-31 2012-06-12 Toray Industries, Inc. Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR148F (da) 1962-01-24
US5776983A (en) 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
AR017340A1 (es) * 1997-10-17 2001-09-05 Astellas Pharma Inc Un derivado de amida, su uso y una composicion farmaceutica que lo comprende.
EP1070046A1 (en) 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives
US6436914B1 (en) * 1998-06-30 2002-08-20 Bristol-Myers Squibb Company 2-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonists
CN1349502A (zh) * 1999-04-01 2002-05-15 旭化成株式会社 经由叠氮化物制备三环氨基－醇衍生物的新方法
US6514991B2 (en) 2000-07-17 2003-02-04 Wyeth Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7417169B2 (en) 2003-10-24 2008-08-26 Kissei Pharmaceutical Co., Ltd. Amino alcohol derivatives, medicinal composition containing the same, and use of these

Also Published As

Publication number Publication date
US8148427B2 (en) 2012-04-03
WO2008093767A1 (ja) 2008-08-07
CN101595088B (zh) 2013-06-19
KR20090104815A (ko) 2009-10-06
KR101479048B1 (ko) 2015-01-05
CA2677061C (en) 2014-07-29
JP4720909B2 (ja) 2011-07-13
AU2008210637B2 (en) 2012-08-16
CN101595088A (zh) 2009-12-02
EP2119700B1 (en) 2012-08-01
ES2387586T3 (es) 2012-09-26
EP2119700A1 (en) 2009-11-18
PL2119700T3 (pl) 2013-01-31
EP2119700A4 (en) 2011-06-08
JPWO2008093767A1 (ja) 2010-05-20
AU2008210637A1 (en) 2008-08-07
PT2119700E (pt) 2012-10-02
US20100099769A1 (en) 2010-04-22
CA2677061A1 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
NO2017002I2 (no) Kobicistat eller farmasøytisk akseptabelt salt derav og atazanavir eller farmasøytisk akseptabelt salt derav
NO2017020I1 (no) Empagliflozin og Linagliptin eller et farmasøytisk akseptabelt salt derav
DK1932470T3 (da) Ekg-adaptersystem og fremgangsmåde til anvendelse deraf
NO2017033I2 (no) baricitinib og farmasøytisk akseptable salter derav
DK2133332T3 (da) (aza)indolderivat og anvendelse deraf til medicinske formål
DK3067064T3 (da) Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
DK2179379T3 (da) Terapiindgivelsessystem med åben opbygning og fremgangsmåde deraf
DK2049525T3 (da) N-laminoheteroaryl)-1H-indol-2-carboxamid-derivater, og fremstilling og terapeutisk anvendelse deraf
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2262803T3 (da) Polysubstituerede derivater af 2-aryl-6-phenyl-imidazo(1,2-A)pyridiner, fremstilling og terapeutisk anvendelse heraf
DK3117828T3 (da) Celleproliferationsfremgangsmåde og farmaceutisk lægemiddel til vævsreparation og -regenerering
DK1922309T3 (da) N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf
EP2170198A4 (en) MEDICAL SYSTEM AND METHOD OF USE
SI2120921T1 (sl) Uporaba aminolevulinske kisline in njenih derivatov
BRPI1007877A2 (pt) "inibidores de dpp-iv para o tratamento de diabetes em pacientes pediátricos"
EP1838291A4 (en) PHARMACEUTICAL FORMULATIONS AND METHOD OF USE THEREOF
HK1117164A1 (en) Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
EP2009006A4 (en) UREIDE DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
DK2313404T3 (da) Quinuclidin-carbonat-derivater og medicinsk sammensætning deraf
NO2016019I1 (no) Oritavancin og farmasøytisk aksepterbare salter derav
ZA201103516B (en) Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
DK2131682T3 (da) Autoklave og fremgangsmåde
DK2158194T3 (da) Derivater af 7-alkynyl-1,8-naphtyridoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
DK1999403T3 (da) Multikoblingssystem og fremgangsmåde relateret dertil
DK2341900T3 (da) Lægemiddelprodukt og behandling